MedicaidPrior AuthMedium impact
Intravenous Iron Products (New)
Humana·OH · Hematology, Nephrology, Oncology +3 more·Medicaid
Effective date
Jan 1, 2026
We identified it
Jun 24, 2026
Summary
Humana Medicaid Ohio now requires prior authorization for intravenous iron products (Feraheme, Injectafer, Monoferric) effective January 1, 2026. Patients must have iron deficiency anemia and have failed or cannot tolerate iron dextran (Infed) and iron sucrose (Venofer) first.
Action Required
Before January 1, 2026: Billing team must update prior authorization procedures for IV iron products (Feraheme, Injectafer, Monoferric) for Humana Medicaid Ohio patients. Providers must document iron deficiency anemia diagnosis and prior therapy failure/contraindication to iron dextran and iron sucrose before administering these medications. Update EMR templates to capture required criteria documentation.